Medicine and Dentistry
Diabetes
90%
Maturity Onset Diabetes of the Young
81%
Cohort Analysis
77%
Insulin Dependent Diabetes Mellitus
65%
Hypoglycemia
35%
Glycemic Control
32%
Cardiovascular Disease
31%
Systematic Review
30%
Insulin Treatment
25%
Randomized Controlled Trial
24%
All Cause Mortality
24%
Diabetes Mellitus
22%
Remote Patient Monitoring
22%
Antidiabetic Agent
19%
Glycon
19%
Digital Health
18%
Glycemic
16%
Meta-Analysis
16%
Amputation
15%
Lifestyle Intervention
15%
Impaired Glucose Tolerance
15%
Meta-Regression
15%
Hemoglobin A1c
14%
Drug Therapy
14%
Population
12%
Blood Glucose
12%
Hazard Ratio
11%
Titrimetry
11%
Primary Health Care
11%
Patient with Diabetes
10%
Sodium Glucose Cotransporter 2 Inhibitor
9%
Telemedicine
9%
Pancreatitis
8%
Patient with Type 1 Diabetes
8%
Retrospective Cohort Study
8%
Cohort Effect
8%
Glucagon-Like Peptide-1 Agonist
7%
Clinical Trial
7%
Glucose Metabolism
7%
Injury
7%
Diabetic Retinopathy
7%
Dual-Energy X-Ray Absorptiometry
7%
Pancreas Cancer
7%
Diabetic Ketoacidosis
7%
Clinical Research
7%
Femur Fracture
7%
SEQUEST
7%
Cross Sectional Study
7%
Diabetic Foot Ulcer
7%
Adolescent
7%
Keyphrases
Type 2 Diabetes Mellitus (T2DM)
52%
Diabetes
36%
Type I Diabetes
32%
Type 1 Diabetes Mellitus (T1DM)
32%
Denmark
24%
Severe Hypoglycemia
23%
Insulin-treated
18%
Hypoglycemia Risk
16%
Patients with Diabetes
16%
Comorbidity
16%
New-onset Diabetes
15%
Major Adverse Cardiovascular Events
15%
All-cause Mortality
15%
National Cohort Study
15%
Contactless
15%
Insulin Therapy
15%
Telemonitoring
15%
Risk Reduction
14%
Pancreatic Cancer
13%
Socioeconomic Status
11%
Patients with Type 2 Diabetes
11%
Randomized Controlled Trial
11%
Insulin Titration
11%
Glycemic Control
11%
Continuous Glucose Monitor
10%
Cancer-related
10%
Hypoglycemic Episodes
10%
Metformin
10%
Bedtime
9%
Nocturnal Hypoglycemia
9%
Glucose-insulin System
9%
Biochemical Parameters
8%
Cardiovascular Disease
8%
Basal Insulin
8%
Pancreatic Ductal Adenocarcinoma
8%
Hemoglobin A1c (HbA1c)
7%
Hypoglycemia
7%
Diabetes Mellitus
7%
Study within a Trial
7%
Glycemic Variability
7%
Amputation
7%
Pancreatic Cancer Risk
7%
Oral Antidiabetics
7%
Perceived Usefulness
7%
Nationwide Register Study
7%
Post-transplant Diabetes Mellitus
7%
Sleep Monitor
7%
Incidence Rate
7%
Type 2 Diabetes Prevention
7%
Vital Parameters
7%
Nursing and Health Professions
Non Insulin Dependent Diabetes Mellitus
100%
Continuous Glucose Monitoring
55%
Insulin Dependent Diabetes Mellitus
48%
Systematic Review
37%
Hypoglycemia
32%
Insulin Treatment
25%
Titrimetry
22%
Telemonitoring
22%
Health Care Personnel
22%
Insulin Injection Pen
15%
Glucose Blood Level
12%
Patient with Type 1 Diabetes
11%
Primary Medical Care
11%
Antidiabetic Agent
11%
Drug Therapy
10%
Insulin Infusion
9%
Logistic Regression Analysis
7%
Cohort Analysis
7%
Pilot Study
7%
Patient with Diabetes
7%
Polysomnograph
7%
Comorbidity
7%
Long Acting Insulin
7%
Cyclorphan
7%
Impaired Glucose Tolerance
7%
Obstructive Lung Disease
7%
Decision Support System
7%
Clinical Decision Support System
7%
Artificial Intelligence
7%
Rate Ratio
6%
Telehealth
6%
Odds Ratio
5%
Hemoglobin A1c
5%
Confidence Interval
5%
Dysglycemia
5%
Primary Health Care
5%
Predictive Value
5%